LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

GLAND

NSEBSE
Gland Pharma Limited
Healthcare· Pharmaceuticals & Biotechnology· INE068V01023· Scrip: 543245
ENहिन्दीગુજરાતીमराठी
1,810.00
59.20 (+3.38%)
4/5/2026, 2:08:56 pm
NSE
1,810.00
59.20
+3.38%
BSE
1,751.00
13.85
+0.00%
1,3961,5761,7551,9342,11305-0206-2708-2510-2312-1902-1804-2704-30
244 trading days · 1Y period
TODAY
Open1,750.80
High1,827.50
Low1,748.00
Prev Close1,750.80
Volume75,896
Value₹13.7Cr
L: 1,748.00H: 1,827.50
52 WEEK
Low1,382.30
High2,131.00
57% of 52W range
Info
Face Value₹1
Listed2020-11-20
ISININE068V01023
SeriesA
BSE Scrip543245

Key Metrics

1D
+1.28%
1W
-1.90%
1M
+5.45%
3M
+5.54%
6M
-9.11%
Valuation
Mkt Cap₹27663 Cr
Growth (QoQ)
Revenue-1.55%
PAT+25.17%
EPS+25.08%
Profitability
Dividend
Yield1.02%
Growth-10.00%
TTM Revenue
₹5729 Cr
TTM EBITDA
₹1447 Cr
TTM PAT
₹704 Cr
TTM EPS
₹42.76
Rev/Share
₹347.7

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr386 Cr773 Cr1159 Cr1545 Cr23-0323-0623-0923-1224-0324-0624-0924-124.811.811.811.711.78.79.912.4
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-311384 Cr1143 Cr396 Cr299 Cr205 Cr12.42
2024-09-301406 Cr1209 Cr351 Cr257 Cr164 Cr9.93
2024-06-301402 Cr1235 Cr310 Cr218 Cr144 Cr8.73
2024-03-311537 Cr1281 Cr391 Cr298 Cr192 Cr11.68
2023-12-311545 Cr1299 Cr389 Cr283 Cr192 Cr11.65
2023-09-301373 Cr1137 Cr371 Cr290 Cr194 Cr11.78
2023-06-301209 Cr985 Cr327 Cr261 Cr194 Cr11.79
2023-03-31785 Cr656 Cr149 Cr111 Cr79 Cr4.78

Shareholding Pattern

CURRENT2026-03-31
51.8%PROMOTER
Promoter51.8%
FII7.3%
DII33.4%
Public48.2%
PROMOTER HOLDING TREND
51.8%24-0651.8%24-0951.8%24-1251.8%25-0351.8%25-0951.8%25-1251.8%26-03

Corporate Actions

Ex-DateTypePurpose
2025-08-14DividendDividend - Rs 18 Per Share
2024-08-16DividendAnnual General Meeting/Dividend - Rs 20 Per Share
2021-08-06Other Annual General Meeting

Earnings Transcripts

Gland Pharma Limited has informed the Exchange about Investor Presentation
3 Nov 2025NSE16K chars
Read →
Gland Pharma Limited has informed the Exchange about Investor Presentation
5 Aug 2025NSE30K chars
Read →
Gland Pharma Limited has informed the Exchange about Investor Presentation
20 May 2025NSE60K chars
Read →
Gland Pharma Limited has informed the Exchange regarding 'Investor presentation'.
3 Feb 2025NSE31K chars
Read →
Gland Pharma Limited has informed the Exchange about Investor Presentation
14 Feb 2024NSE15K chars
Read →
Gland Pharma Limited has informed the Exchange about Investor Presentation
6 Nov 2023NSE16K chars
Read →
Gland Pharma Limited has informed the Exchange about Investor Presentation
7 Aug 2023NSE15K chars
Read →
Gland Pharma Limited has informed the Exchange about Investor Presentation
18 May 2023NSE43K chars
Read →
Gland Pharma Limited has informed the Exchange about Earnings call Transcript for Q3FY23
31 Jan 2023NSE55K chars
Read →
Gland Pharma Limited has informed the Exchange about Investor Presentation
23 Jan 2023NSE13K chars
Read →
Gland Pharma Limited has informed the Exchange about the Presentation on the Proposed Acquisition of...
29 Nov 2022NSE12K chars
Read →
Gland Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investor M...
2 Nov 2022NSE52K chars
Read →
Gland Pharma Limited has informed the Exchange about Investor Presentation for Q2FY23
26 Oct 2022NSE13K chars
Read →
Gland Pharma Limited has informed the Exchange about Earnings Conference Call - Q2FY23
11 Oct 2022NSE3K chars
Read →
Gland Pharma Limited has informed the Exchange about Transcript of Earnings call for Q1FY23
27 Jul 2022NSE58K chars
Read →
Gland Pharma Limited has informed the Exchange about Investor Presentation on the Q1FY23 Financial R...
20 Jul 2022NSE11K chars
Read →
Gland Pharma Limited has informed the Exchange about Earnings Conference Call - Q1FY23
5 Jul 2022NSE2K chars
Read →
Gland Pharma Limited has informed the Exchange about Transcript of Earnings call Transcript for Q4FY...
26 May 2022NSE50K chars
Read →
Gland Pharma Limited has informed the Exchange about Investor Presentation on Q4FY22 Financial Resul...
19 May 2022NSE41K chars
Read →
Gland Pharma Limited has informed the Exchange about Earnings Conference Call - Q4FY22
4 May 2022NSE2K chars
Read →

Price History

DateOpenHighLowCloseVolume
2026-04-301,747.501,767.301,728.401,750.802.21L
2026-04-291,767.801,776.301,735.101,739.1037,857
2026-04-281,773.101,773.101,745.001,760.8080,928
2026-04-271,717.601,781.301,711.001,775.501.13L
2026-04-241,791.501,798.101,702.901,713.501.62L
2026-04-231,786.601,832.001,782.001,795.4055,778
2026-04-221,780.001,818.101,774.001,800.6091,491
2026-04-211,785.601,792.801,761.601,781.001.10L
2026-04-201,796.001,811.901,763.001,794.6096,610
2026-04-171,736.001,811.201,736.001,797.401.43L
2026-04-161,752.701,771.101,720.901,735.602.76L
2026-04-151,750.001,782.801,726.501,752.7069,406
2026-04-131,701.101,749.001,693.301,724.3053,303
2026-04-101,745.101,771.001,732.001,741.9053,183
2026-04-091,728.501,755.601,721.801,749.1031,364
2026-04-081,755.001,755.001,706.501,728.5040,456
2026-04-071,704.001,721.801,672.001,716.401.31L
2026-04-021,686.001,706.601,652.001,688.6095,788
2026-04-011,701.701,735.001,690.201,706.0070,584
2026-03-271,700.501,790.001,680.101,724.1090,957
2026-03-251,689.001,727.001,670.201,710.5058,101
2026-03-241,630.301,679.601,616.301,670.2083,880
2026-03-201,597.001,631.501,587.701,627.101.38L
2026-03-191,651.001,651.001,592.801,596.8037,796
2026-03-181,655.001,705.501,629.101,664.802.12L
2026-03-171,633.001,640.001,601.301,633.9029,951
2026-03-161,603.101,620.001,573.601,609.2057,547
2026-03-131,640.101,656.901,601.701,626.601.11L
2026-03-121,669.901,699.901,638.301,655.301.73L
2026-03-111,673.701,715.001,657.201,667.0082,417

Frequently Asked Questions

About

Gland Pharma Limited is an Indian-based manufacturer of generic injectables, specializing in sterile formulations, oncology, and ophthalmic products, with a focus on complex injectables and New Chemical Entities. The company operates globally, supplying to markets including the United States, Europe, and India, and is recognized as one of the world's fastest-growing generic injectable manufacturers.

Advertisement
BOARD OF DIRECTORS
Srinivas Sadu
Managing Director
DEPARTED
Essaji Goolam Vahanvati
Independent Director
Satyanarayana Murthy Chavali
Independent Director

Mutual Fund Holdings

4 funds · bar length = % to NAVBrowse all funds →
hdfc3 schemes
HDFC Mid Cap Fund
1.26%
₹10.7K Cr
HDFC Large and Mid Cap Fund
0.94%
₹2.4K Cr
HDFC NIFTY SMALLCAP 250 INDEX FUND
0.79%
₹4 Cr
baroda1 scheme
Baroda BNP Paribas Health and Wellness Fund
0.03%
₹15 Cr